Stock Events

Acadia Pharmaceuticals (ACAD) Q3 2014 Earnings

5AugConfirmed
Q4 2013
Q1 2014
Q2 2014
Q3 2014
-0.22
-0.19
-0.15
-0.12

Details

Expected EPS
-0.19
Actual EPS
-0.22
Surprise EPS
-0.03
Surprise Percent
+15.79%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.22 per share for Q3 2014.

0 Comments

Share your thoughts